Ginkgo Bioworks Holdings, Inc. Class A (DNA) earnings
DNA earnings moved a median of -2.27% by the close. Quarterly and annual DNA reports and results, each read against the price at its own news timestamp. Back to the DNA overview →
27 measured DNA earnings events.
Where these DNA earnings landedvs 27 measured DNA earnings reactions
| Middle 50% of DNA earnings reactions | -9.29% to +3.72% |
|---|---|
| Median reaction (to close) | -2.27% |
| Measured reactions | 27 |
Point-in-time · zero look-ahead
Half of the 27 DNA earnings events with a measured close landed between -9.29% and +3.72%; 44% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Ginkgo Bioworks Holdings For: Sep 30 | SEC filing · Form 10-Q | -3.77% | -3.77% | |
| Ginkgo Bioworks Reports Third Quarter 2026 Results; Signs First Autonomous Lab Sale to a Top-Tier Pharma Company Novo | Press release | -2.68% | +8.87% | |
| Form 10-Q Ginkgo Bioworks Holdings For: Jun 30 | SEC filing · Form 10-Q | -8.24% | -4.09% | |
| Form 10-Q Ginkgo Bioworks Holdings For: Mar 31 | SEC filing · Form 10-Q | +4.65% | +3.72% | |
| Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab | Press release | +4.65% | +3.72% | |
| Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation | Press release | +1.73% | +12.35% | |
| Form 10-K Ginkgo Bioworks Holdings For: Dec 31 | SEC filing · Form 10-K | -2.65% | -16.46% | |
| Form 10-Q Ginkgo Bioworks Holdings For: Sep 30 | SEC filing · Form 10-Q | -2.72% | -13.02% | |
| Ginkgo Bioworks Reports Third Quarter 2025 Financial Results | Press release | -2.72% | -13.02% | |
| Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation | Press release | +0.41% | +7.09% | |
| Form 10-Q Ginkgo Bioworks Holdings For: Jun 30 | SEC filing · Form 10-Q | -2.53% | -12.53% | |
| Ginkgo Bioworks Reports Second Quarter 2025 Financial Results | Press release | -2.53% | -12.53% | |
| Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation | Press release | +0.70% | +2.26% | |
| Form 10-Q Ginkgo Bioworks Holdings For: Mar 31 | SEC filing · Form 10-Q | -1.61% | +8.35% | |
| Ginkgo Bioworks Reports First Quarter 2025 Financial Results | Press release | -1.61% | +8.35% | |
| Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation | Press release | -0.42% | +3.22% | |
| Form 10-K Ginkgo Bioworks Holdings For: Dec 31 | SEC filing · Form 10-K | +1.67% | +1.22% | |
| Form 10-Q Ginkgo Bioworks Holdings For: Sep 30 | SEC filing · Form 10-Q | +3.30% | -5.39% | |
| Ginkgo Bioworks Reports Third Quarter 2024 Financial Results | Press release | +3.30% | -5.39% | |
| Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation | Press release | +0.27% | +6.11% | |
| Form 10-Q Ginkgo Bioworks Holdings For: Jun 30 | SEC filing · Form 10-Q | +2.32% | -12.84% | |
| Ginkgo Bioworks Reports Second Quarter 2024 Financial Results | Press release | +2.32% | -12.84% | |
| Ginkgo Bioworks Announces Date of Second Quarter 2024 Results Presentation | Press release | -1.32% | -2.27% | |
| Form 10-Q Ginkgo Bioworks Holdings For: Mar 31 | SEC filing · Form 10-Q | -2.04% | -6.06% | |
| Ginkgo Bioworks Reports First Quarter 2024 Financial Results | Press release | -2.04% | -6.06% | |
| Ginkgo Bioworks Announces Date of First Quarter 2024 Results Presentation | Press release | -0.67% | -1.94% | |
| Form 10-K Ginkgo Bioworks Holdings For: Dec 31 | SEC filing · Form 10-K | -3.52% | +0.78% |
Keep exploring
More DNA: analyst actions → · SEC filings → · DNA overview →